Clinical Trial Update: Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated a booster dose of the meningococcal diphtheria toxoid conjugate vaccine in adolescents; results were posted after completion in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcemia

Drugs mentioned

• Meningococcal Diphtheria Toxoid Conjugate Vaccine (Meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcemia | Phase 2 | Status: COMPLETED | Results posted: 2009-03-19